| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.6B | $0.5B | $0.5B | $0.4B | $0.4B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $1.57 | $1.27 | $1.32 | $1.23 | $1.24 | $0.22 | $0.29 | $0.30 |
| EPS (Diluted) | $1.56 | $1.27 | $1.31 | $1.22 | $1.23 | $0.22 | $0.29 | $0.30 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $50.2B | $48.6B | $46.2B | $43.7B | $39.5B | $37.4B | $34.6B | $33.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $2.5B | $2.4B | $1.6B | $1.7B | $3.5B | $1.4B | $0.6B | $0.5B |
| Total Liabilities | $43.5B | $42.3B | $40.1B | $38.1B | $34.4B | $32.4B | $29.7B | $28.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $6.8B | $6.3B | $6.0B | $5.7B | $5.2B | $5.0B | $4.9B | $4.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.6B | $0.4B | $1.2B | $0.5B | $0.1B | $0.3B | $0.6B |
| Investing Cash Flow | $-1.5B | $-1.7B | $-2.3B | $-3.1B | $-0.2B | $-1.8B | $-1.1B | $-1.9B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $1.1B | $1.9B | $1.7B | $0.0B | $1.7B | $2.5B | $1.0B | $1.3B |